Vaccination critical to protect against both illnesses

HONOLULU – Dr. Sarah Kemble, Hawaiʻi Department of Health state epidemiologist, released the following statement on mortality rates involving COVID-19 and influenza:

“In Hawaiʻi and around the world, COVID-19 was far deadlier than the flu during the 2020-2021 flu season. There was one confirmed influenza death in Hawaiʻi between Sept. 27, 2020 and Oct. 2, 2021. This is compared to 608 COVID-19 deaths in the same reporting period. While influenza deaths have been rare in the past season, the upcoming season is a big unknown. If mitigation measures are loosened as COVID cases come down, it is likely we will see some resurgence of flu and other respiratory diseases.”

“DOH strongly recommends that all eligible individuals get vaccinated against both flu and COVID-19. It is safe to receive both vaccinations at the same time. Getting the flu shot will help to ensure that Hawai‘i’s flu rates remain low to protect our hospital capacity and keep our communities healthy.”

Pneumonia and influenza related mortality data referenced in DOH’s Influenza/Respiratory Disease Surveillance Report is an aggregate of pneumonia caused by all infectious agents, including flu and COVID-19.

# # #

 

PDF DOH: COVID-19 Far Deadlier Than Influenza

 

Categories: News Releases, Vaccine
Recent Posts

Hawai‘i COVID-19 hospitalizations on the rise

HONOLULU, HI – The Hawai‘i Department of Health (DOH) reports a rise in the rate of COVID-19 hospitalizations. The number of total positive COVID-19 hospitalizations has increased over the past week (3/26 – 4/4) from [...]

Wastewater Samples Show Higher COVID Concentrations & New Subvariant

The Hawai‘i State Department of Health’s most recent Wastewater Surveillance Report documents two significant developments about COVID-19 in Hawai‛i. Higher concentrations of the virus that causes COVID-19 The arrival of the XBB.1.5 subvariant Higher concentrations [...]

Bivalent boosters for keiki as young as 6 months

Updated COVID-19 bivalent boosters are now available in all counties for keiki as young as six months of age. The U.S. Food and Drug Administration (FDA) amended the emergency use authorization for the bivalent boosters [...]

Select Archive Month